CalciMedica Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates
CalciMedica Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: CalciMedica Secures Credit Facility For Up To $32.5 Million
Brief: CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
CalciMedica Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Calcimedica Reports Third Quarter 2024 Financial Results And Provides Clinical & Corporate Updates
Brief: CalciMedica Strengthens Leadership Team With Appointment Of Stephen Bardin As Chief Financial Officer
CalciMedica Inc expected to post a loss of 50 cents a share - Earnings Preview
Brief: Calcimedica Announces Pricing Of Public Offering Of Common Stock
Brief: Calcimedica Announces Proposed Public Offering Of Common Stock
CalciMedica Inc reports results for the quarter ended in June - Earnings Summary
CalciMedica Inc expected to post a loss of 53 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Equity Residential, Goldman Sachs, Marsh & Mclennan
Brief: Calcimedica Announces Positive Topline Data From Phase 2B Carpo Trial Of Auxora™ In Acute Pancreatitis (AP)
CalciMedica Inc reports results for the quarter ended in January - Earnings Summary
CalciMedica Inc expected to post a loss of 67 cents a share - Earnings Preview
Brief: CalciMedica Announces Last Patient Enrolled In Phase 2B Carpo Trial Of Auxora
Brief: Calcimedica Says May Offer, Sell Shares Of Common Stock Of Up To $17.1 Million From Time To Time Through Wainwright